Γ—

Novo Biosciences

Organization Description

Novo Biosciences have identified the first drug candidate shown to stimulate a damaged heart to repair itself by spurring regeneration in the cells so that the organ repairs itself like it did during development and like organs such as the liver do.

To do this, we need your support. Your charitable contribution tranforms into rejuvenation research, news, shows, and more. Will you help?

Team

Kevin Strange, Ph.D.

Novo Biosciences - CEO